Chicago Atlantic BDC
Inside Chicago Atlantic BDC’s $335M private-credit portfolio — 51 holdings disclosed in SEC filings. The portfolio is 99% first-lien by fair value, a weighted-average spread near 833 bps.
Aug 13 · SEC EDGAR
Credit Snapshot
How the market and the balance sheet read LIEN as a credit: NAV per share is the Q2 FY2026 book value ($13.26) from its SEC quarterly filing — for a BDC, book value is NAV. Fair values underneath are the manager’s own estimates. Price as of 2026-08-26.
| Metric | Value | What healthy looks like |
|---|---|---|
| Price-to-NAV | 0.77x (discount) | Quality BDCs tend to trade near NAV; a deep discount often signals credit concern — or opportunity to investigate. |
| Dividend Yield (FY2025 paid) | 10.0% | A trailing all-in yield (full-year dividends paid, including any specials) — not a forward run-rate. BDC regular yields typically run 8–12%; treat an outlier as a question about dividend sustainability. |
| Dividend Coverage (GAAP NII) | 1.42x GAAP NII ÷ FY2025 distributions | Above 1.0x, the year’s distributions were earned by investment income; below 1.0x they exceeded it — watch for a cut or return-of-capital funding. GAAP NII, not the manager’s adjusted “core NII”. |
| NII Return on Equity | 10.9% GAAP NII on FY2025 FY-end NAV | What the portfolio EARNED on book value, before mark swings — steadier than mark-driven ROE. BDCs typically land high single digits to low teens; internally managed books keep more of it. |
| NAV Total Return | -50.8% FY2025: ΔNAV/share + distributions | NAV change plus distributions, per share — what the book earned independent of market sentiment. Sustained positive NAV total return means the credit book is creating value, not just distributing it back. |
| Top-5 Borrower Concentration | 39% of portfolio FV ≈ 43% of Q2 FY2026 NAV largest: U.S. Debt Cannabis Verano Holdings Corp. Facility Type Term Loan All in Rate 11.66% Benchmark S (11.3% of FV) | Measured against NAV, not just portfolio value: leverage means one borrower’s writedown hits book value harder than its portfolio share suggests. Diversified BDCs typically keep any single name to a low single-digit share of the portfolio. |
| Debt Marked Below 90 | 4.2% of marked debt FV (100% coverage) | Loans marked below 90 cents on the dollar are the book’s watchlist; a growing tail often precedes non-accrual. |
| PIK Income Share | 100.0% of debt FV carries a PIK component | Interest paid “in kind” adds to the loan instead of paying cash; a rising PIK share is the classic early sign of borrower stress. |
| Floating-Rate Mix | 0% floating of rate-classified debt (100% coverage); the rest fixed | Floating-rate loans reprice with their benchmark (mostly SOFR), so a high floating share means portfolio income rises when the Fed hikes and falls when it cuts — the book’s rate sensitivity in one number. |
| Non-Accruals | — not yet parsed | 1–3% of debt fair value is normal; 5%+ is a warning sign. We don’t parse this yet — check the latest 10-Q. |
| Fee Structure — manager economics, from the same annual filing | ||
| Base Management Fee | $5.5M ≈1.59% of FY2025 FY-end total assets, our calculation — contractual fees accrue on average gross assets as filed, gross of any fee waivers | External BDC base fees typically run 1.0–1.75% of assets — charged on ASSETS, not equity, so leverage raises the fee bill on the same NAV. |
| Incentive Fee | $8.3M ≈20.1% of pre-fee investment income as filed, gross of any fee waivers | Income incentive fees typically take 17.5–20% of pre-fee investment income over a hurdle. A capital-gains fee in an up-mark year is not recurring income economics — watch the split. |
Portfolio Composition
Portfolio-wide breakdown by fair value across this BDC’s full Schedule of Investments. Source: SEC EDGAR (public). As of the 2026-08-13 filing.
Maturity Wall
Debt fair value by each loan’s stated maturity year (100% of debt FV carries a parsed maturity). The refinancing question: 16% of the maturity-dated book comes due by end-2027 — debt that must be repaid, refinanced, or extended. As of the 2026-08-13 filing.
| Maturing | Debt FV | % of dated debt |
|---|---|---|
| 2026 or earlier | $15M | 4.6% |
| 2027 | $38M | 11.6% |
| 2028 | $130M | 39.1% |
| 2029 | $106M | 31.9% |
| 2030 | $23M | 6.9% |
| 2031+ | $19M | 5.9% |
Manager Track Record
Through-the-cycle indicators computed from filed schedule-of-investments data: the non-accrual level and its four-quarter direction, the fleet standing among BDCs whose latest filing clears the 90% determinate-coverage gate, and the average debt mark against a year earlier. A track record, not a verdict — each row is coverage-gated and omitted when the data doesn’t support it. As of the 2026-08-13 filing.
| Avg debt mark vs 4q ago | 99.4 vs 100.3 (-0.9 pts) |
Quarter-over-quarter changes
Borrowers added to and dropped from the book between the 2026-05-14 and 2026-08-13 filings, and the largest weighted-mark moves on borrowers held across both. Aggregated to the borrower so a company’s exposure is counted once even when its loan tranches are re-cut quarter to quarter; entries and exits under $0.5M are omitted as parse noise.
New this quarter 8
- Canadian Debt Cannabis - Canopy Growth Corporation Facility Type Term Loan All In Rate 9.87% Benchmark S$14M
- U.S. Debt Cannabis Kapple Holdings Llc ((D/B/A Cannabis & Glass) Facility Type Delayed Draw Term Loan All In Rate 14.25% Benchmark S$6M
- All In Rate 12.65% Benchmark S$6M
- U.S. Debt Cannabis Wellgreens 2.0, Llc Facility Type Term Loan All In Rate 14.00% Benchmark P$4M
- Protect Animals With Satellites Llc (Halo Collar) Facility Type Term Loan All In Rate 12.00% Benchmark P$4M
- U.S. Debt Hugo Technologies, Inc. Facility Type Term Loan All In Rate 11.62% Benchmark S$3M
Exited 11
- U.S. Debt Cannabis Co Acquisition Vehicle, Llc Facility Type Term Loan All In Rate 20.00% Benchmark F$17M
- Canadian Debt Cannabis - Canopy Growth Corporation Facility Type Term Loan All In Rate 9.91% Benchmark S$14M
- U.S. Debt Cannabis Elevation Cannabis, Llc Facility Type Delayed Draw Term Loan All In Rate 16.25% Benchmark P$7M
- U.S. Debt Cannabis Kapple Holdings Llc (Cannabis & Glass) Facility Type Delayed Draw Term Loan All In Rate 14.25% Benchmark S$6M
- U.S. Debt Cannabis Wellgreens Facility Type Term Loan All In Rate 14.00% Benchmark P$4M
- U.S. Debt Information Protect Animals With Satellites Llc (Halo Collar) Facility Type Term Loan All In Rate 12.00% Benchmark P$4M
Biggest mark moves
- U.S. Debt Cannabis Fluent Corp. Facility Type Term Loan All In Rate 13.00% Benchmark F↑ 99→108
- U.S. Debt Retail Trade Aura Home, Inc Facility Type Term Loan All In Rate 10.15% Benchmark S↓ 100→97
- U.S. Debt Cannabis Aeriz Holdings Corp Facility Type Delayed Draw Term Loan All In Rate 12.75% Benchmark P↓ 97→96
- U.S. Debt Cannabis Theratrue, Inc. Facility Type Delayed Draw Term Loan All In Rate 14.50% Benchmark F↑ 100→102
- All In Rate 12.75% Benchmark F↓ 98→97
- U.S. Debt Cannabis Illicit - S1 Enterprises, Inc Facility Type Term Loan All In Rate 13.96% Benchmark S↑ 97→98
Top Portfolio Holdings
| # | Company | Type | Coupon | Maturity | Fair Value | % of FV | % of Net Assets |
|---|---|---|---|---|---|---|---|
| 1 | U.S. Debt Cannabis Verano Holdings Corp. Facility Type Term Loan All in Rate 11.66% Benchmark S | 1L Sr SecuredPIK 0.00% | SOFR + 7.66% | Mar 2029 | $38M | 11.3% | 12.5% |
| 2 | U.S. Debt Cannabis Dreamfields Brands, Inc. (d/b/a Jeeter) Facility Type Delayed Draw Term Loan All in Rate 16.25% Benchmark P | 1L Sr SecuredPIK 0.00% | Prime + 8.75% | Sep 2028 | $31M | 9.3% | 10.3% |
| 3 | U.S. Debt Cannabis Verano Holdings Corp. Facility Type Revolver All in Rate 12.33% Benchmark S | 1L Sr SecuredPIK 0.00% | SOFR + 8.33% | Feb 2029 | $26M | 7.9% | 8.7% |
| 4 | All in Rate 15.00% Benchmark F | 1L Sr SecuredPIK 0.00% | Fixed Rate + 15.00% | Oct 2028 | $22M | 6.6% | 7.3% |
| 5 | Canadian Debt Cannabis - Canopy Growth Corporation Facility Type Term Loan All in Rate 9.87% Benchmark S | 1L Sr SecuredPIK 0.00% | SOFR + 6.25% | Jan 2031 | $14M | 4.2% | 4.6% |
| 6 | U.S. Debt Cannabis Flowery - Bill's Nursery, Inc Facility Type Delayed Draw Term Loan All in Rate 16.00% Benchmark F | 1L Sr SecuredPIK 5.00% | Fixed Rate + 11.00% | Dec 2027 | $13M | 4.0% | 4.5% |
| 7 | U.S. Debt Cannabis Illicit - S1 Enterprises, Inc Facility Type Term Loan All in Rate 13.96% Benchmark S | 1L Sr SecuredPIK 0.00% | SOFR + 10.24% | Dec 2028 | $13M | 4.0% | 4.4% |
| 8 | U.S. Debt Cannabis Nova Farms, LLC Facility Type Term Loan All in Rate 15.00% Benchmark P | 1L Sr SecuredPIK 0.00% | Prime + 6.50% | Mar 2027 | $13M | 3.9% | 4.4% |
| 9 | U.S. Debt Cannabis BeLeaf Medical, LLC Facility Type Term Loan All in Rate 13.25% Benchmark P | 1L Sr SecuredPIK 0.00% | Prime + 5.75% | Aug 2028 | $12M | 3.7% | 4.1% |
| 10 | U.S. Debt Cannabis Wyld - Northwest Commonwealth, LLC (d/b/a WYLD) Facility Type Term Loan All in Rate 16.67% Benchmark P | 1L Sr SecuredPIK 1.50% | Prime + 8.42% | Jan 2029 | $12M | 3.4% | 3.8% |
| Full schedule — all 51 holdings, sortable and screenable → | |||||||
% of net assets reads each position against stockholders’ equity as of Q2 FY2026 — on a levered book, a position is a larger share of the equity that absorbs losses than of portfolio fair value.
This page is the public file — the Ledge adds
Borrower cross-reference
Search any borrower, see every BDC exposed to it.
Quarterly diffs
What entered and exited the book each quarter.
Book-structure risk
Senior-secured, floating-rate and PIK share — how the book is built.
Loan-Pricing Trend
Fair-value-weighted average credit spread and average mark across this BDC’s Schedule-of-Investments debt holdings, by filing quarter. Mark is fair value as a percent of par (100 = par). Spread is in basis points over each loan’s own benchmark, normalized from the filing’s as-reported units. Source: SEC EDGAR (public). Spreads have widened from 762 to 833 bps over 11 quarters while marks held near 98.
| Quarter | Borrowers | Priced Positions | Wtd-Avg cash spread (bps) | Avg Mark (% of par) | Debt Fair Value |
|---|---|---|---|---|---|
| Q3 2024 | 1 | 3 | 767 | 97.2 | $56M |
| Q2 2025 | 36 | 36 | 843 | 100.3 | $306M |
| Q3 2025 | 39 | 40 | 832 | 98.6 | $310M |
| Q4 2025 | 40 | 41 | 834 | 99.0 | $332M |
| Q1 2026 | 40 | 41 | 841 | 98.6 | $361M |
| Q2 2026 | 38 | 39 | 833 | 99.4 | $332M |
3 quarters omitted — filing not parsed.
Marks reflect each BDC’s own fair-value estimates as reported to the SEC, not traded prices. Private-credit loans are predominantly Level 3 under ASC 820 — valued from unobservable inputs and determined in good faith by each BDC’s board, so figures are estimates as of the filing date and are not directly comparable across managers. Informational only; not investment advice or a valuation.
Questions this page answers
What does Chicago Atlantic BDC invest in?
Chicago Atlantic BDC's portfolio breaks down by total portfolio fair value into approximately 99% first-lien senior secured, 0% second-lien or mezzanine, 0% other or unclassified debt, and 1% equity or other as of its 2026-08-13 SEC filing.
How large is Chicago Atlantic BDC's portfolio?
Chicago Atlantic BDC reported $335M in portfolio fair value across 51 holdings and 48 unique borrowers as of its 2026-08-13 SEC filing.
Where does this data come from?
This data is parsed by Oxford Ledge from Chicago Atlantic BDC's Schedule of Investments in its SEC EDGAR filings. Fair values are the manager's own estimates as of the 2026-08-13 filing date.
About Chicago Atlantic BDC
Chicago Atlantic BDC (LIEN) is a publicly traded Business Development Company (BDC) — essentially a publicly listed fund that lends money to mid-sized private companies. In plain English: BDCs raise money from public investors and lend it to businesses that are too small for Wall Street banks. To qualify for pass-through tax treatment, they distribute at least 90% of their taxable investment income to shareholders, which is why BDC yields are often 8–12%. Chicago Atlantic BDC discloses its full loan portfolio through SEC filings.